This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., Emory University, Harvard College. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021
Title: Innovations by Masao Hashimoto: Pioneering Immunotherapy Solutions
Introduction
Masao Hashimoto is an accomplished inventor based in Decatur, GA, known for his significant contributions to the field of immunotherapy. He holds a patent that focuses on improving therapeutic outcomes for patients through innovative methods targeting immune cell interactions in the liver.
Latest Patents
Hashimoto's patent, titled "Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors," outlines transformative strategies for reducing specific immune cell populations. This patent presents methods and compositions aimed at enhancing diagnostic, prognostic, and therapeutic practices related to liver immunology.
Career Highlights
Throughout his career, Hashimoto has made noteworthy strides in the field of cancer research. He has collaborated with prominent institutions such as the Dana-Farber Cancer Institute Inc. and Harvard College. His work has encompassed innovative research methodologies that seek to optimize treatment approaches for cancer patients.
Collaborations
In his professional journey, Hashimoto has worked closely with esteemed colleagues, including Gordon James Freeman and Rafi Ahmed. Their collaborative efforts have significantly advanced understanding and treatment of various cancers and immune-related conditions, underlining the importance of teamwork in scientific research and discovery.
Conclusion
Masao Hashimoto’s contributions to immunotherapy not only highlight his inventive capabilities but also reflect the ongoing pursuit of innovation in medical research. His work continues to pave the way for new diagnostic and treatment solutions, offering hope for numerous patients in need of advanced therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile